non-gmp
22 Results
高级搜索
Search Within Add keywords to narrow your search results
-
-
Press Release: Merck Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea
Merck today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia. -
Press Release: Merck to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai
Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck's Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China. -
Press Release: Merck Brings Biotechs Closer to Drug Therapy Production and Commercialization
Merck today officially opened North America's first BioReliance® End-to-End Biodevelopment Center in Burlington, Massachusetts, U.S.A., providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers. -
Biopharmaceutical Application Guide | Merck
Find the products and services for your process. -
Press Release: Merck Opens China's First BioReliance® End-to-End Biodevelopment Center in Shanghai
Merck today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region. -
PharmaGrade™ - Emprove® Integration | Merck
Our current PharmaGrade™ products - which include specialty chemicals, buffers, and amino acids - will be integrated into the Emprove® program. -
Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe
Merck expands its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise. -
Press Release: Merck Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name
Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies. -
Press Release: Merck Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
Merck today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck.